Truly honored to be among the first Netherlands Academy of Engineering fellows https://t.co/sw3jx3NFpS We will be inaugurated on November 13, celebrating #problemsolving through #engineering and pushing #innovation academically & through #entrepreneurship https://t.co/aXpxSzruJn

The Trained Therapeutix crew at Glenn's wedding💒 We are getting closer and closer to dosing the first patient🏥 Grateful🙏 for this dreamteam! https://t.co/IhNDYAnM06

Dit is meer dan schandalig: dit is gewoon eng. Met meerdere organisaties (en wrs vooral mannen) demonstreren tegen één vrouw, een professor van @erasmusuni. Als we hier nu niet tegen optreden, wordt er iets fundamenteels kapotgemaakt in ons land: de (academische) vrijheid zelf.

Our new, comprehensive review on CAR T cell persistence is officially published in @CellCellPress @trendscancer. Fantastic work from lead authors @kpmueller1 @JGrenierMDPhD. Link to the full article: https://t.co/4a0lsoqHtm

A few weeks after founding https://t.co/yhYvysamda in 2019, I received an email from @jozeephus "I am a drug 💊 developer and I can help advance your innovative immunotherapy to the clinic." Proud to announce that Joost Kreijtz has been appointed CEO of Trained Therapeutix NL!

We starting building a new bioengineering group 5 years ago. I am excited to share we just received the support to develop our aNP platform into an immunotherapy modality for patients. DRIVIN’CAR🏎️ Developing Robust In VIvo Nanomedicine-based Chimeric Antigen Receptor technology

Microenvironmental regulation of solid tumour resistance to CAR T cell therapy

My university cites academic freedom to excuse rampant antisemitism on campus. I'll use my academic freedom to continue collaborating with my dear Israeli colleagues. While yesterday's historic events spark hope for Middle East peace, some campuses remain morally adrift. 🇮🇱🇵🇸✌️

✨Honored to present @ESGCT #Seville! 🇪🇸✨ My invited talk was on “RNA-Based Nanomedicines for Myocardial Infarction Repair: Mending the Broken Hearts”.Big thanks for the opportunity to share our vision of how RNA nanotherapeutics can work together to heal broken hearts. ❤️🔬

We had an amazing early morning session at the @ESGCT #Seville,Nanomedicines for gene delivery: From research to clinical translation. Happy to had co-chaired with prof. Maria Jose Alonso our 2 super amazing invited talks of prof. @WillemNANO and prof. @MK_CCI.Thanks for coming!

Great session to start the day at @ESGCT #ESGCT on #nanomedicine for #gene delivery with @WillemNANO presenting on that sweet #aNP technology and @MK_CCI on #LNP for #neuroblastoma treatment

Yesterday was special! Cas, Marc (sponsees) and I had a windsurfing 🌬️🏄session together, epic conditions at the IJsselmeer. And Cas' dad @Jaapsurf made this awesome video! 🤙

In vivo CAR-T cell therapy https://t.co/VZojof7D8T https://t.co/BIxZAyySli This new Review discusses how technological advances that remove the need for ex vivo manipulation and chemotherapeutic conditioning could enable wider application of CAR-T cell therapies

Super proud of Yohana’tje subbing in for me at WMIC. All the way in Alaska!

Checkpoint inhibitors are the mainstay of cancer immunotherapy. Here's a new review article for the current state of the science and where we're headed @SciImmunology https://t.co/YNDp5YvKuc

Watching the @radboudumc team operate like a well-oiled machine on a Trained Therapeutix project is inspiring!🚀And a beautiful example of crossing bridges to advance next generation immunotherapy. https://t.co/Appg2MvOOA @jozeephus

𝐈𝐦𝐦𝐮𝐧𝐨𝐬𝐮𝐩𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 is the inhibition of unwanted immune responses that, in the context of allo-transplantation, would otherwise result in the rejection of a foreign (or histoincompatible) organ or cellular graft. Immunosuppressive drugs are also used to treat

Ik ben diep teleurgesteld in de @_knaw, vanwege deze verklaring: https://t.co/9oqwkowVPd Wat mij betreft, gaat het hier op twee fundamentele punten mis. 1/

Cancer is an evolutionary disease, but does knowing a cancer’s evolutionary past help predict its future? Out today in @Nature, we learnt the evolution of 2000 lymphoid cancers and found it was highly correlated with clinical outcomes! (1/7, link below)

Ideologies claiming liberalism or democracy but relying on manipulation, censorship, and violence are neither.

For readers interested in cancer therapies, this review discusses how metabolic dysfunction of CD8 T cells and NK cells can diminish their anticancer activity, and assesses therapeutic strategies to overcome this https://t.co/e9kmLRW4tV https://t.co/EvyaEKg59v